Other publication

Quantitative drug sensitivity and resistance testing (DSRT) of primary ex vivo AML blasts highlights mTOR and MEK as potential key molecular driver signals of therapeutic significance




AuthorsPemovska T, Kylesskiy E, Kontro M, Szwajda A, Karjalainen R, Majumder MM, Malani D, Bespalov MM, Eldfors S, Elonen E, Knowles J, Murumagi A, Mpindi JP, Edgren H, Venkata NPK, Turunen L, Mustjoki S, Wolf M, Yadav B, Aittokallio T, Heckman CA, Porkka K, Kallioniemi O, Wennerberg K

PublisherAMER ASSOC CANCER RESEARCH

Publication year2012

JournalCancer Research

Journal name in sourceCANCER RESEARCH

Journal acronymCANCER RES

Volume72

Number of pages1

ISSN0008-5472

DOIhttps://doi.org/10.1158/1538-7445.AM2012-895




Last updated on 2024-26-11 at 20:45